192 related articles for article (PubMed ID: 20519818)
1. Reversible posterior leukoencephalopathy syndrome (RPLS) in a heart transplant recipient treated by substitution of cyclosporine A with tacrolimus.
Oda N; Kato TS; Hanatani A; Niwaya K; Nakatani T; Ishibashi-Ueda H; Kitamura S; Hashimura K; Kitakaze M; Komamura K
Intern Med; 2010; 49(11):1013-6. PubMed ID: 20519818
[TBL] [Abstract][Full Text] [Related]
2. Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients.
Akutsu N; Iwashita C; Maruyama M; Ootsuki K; Ito T; Saigo K; Kenmochi T
Transplant Proc; 2008 Sep; 40(7):2416-8. PubMed ID: 18790253
[TBL] [Abstract][Full Text] [Related]
3. Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy.
Kapoor A; Birks E; Lenneman A; McCants K
Tex Heart Inst J; 2017 Jun; 44(3):205-208. PubMed ID: 28761402
[TBL] [Abstract][Full Text] [Related]
4. Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
Heidenhain C; Puhl G; Neuhaus P
Exp Clin Transplant; 2009 Sep; 7(3):180-3. PubMed ID: 19715529
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
6. Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report.
Ramirez R; Muskula PR; Everley MP
Am J Case Rep; 2017 May; 18():487-490. PubMed ID: 28465499
[TBL] [Abstract][Full Text] [Related]
7. Two patients with focal segmental glomerulosclerosis complicated by cyclosporine-induced reversible posterior leukoencephalopathy syndrome.
Sakai N; Kawasaki Y; Imaizumi T; Kanno S; Go H; Mitomo M; Ushijima Y; Suyama K; Ito M; Hashimoto K; Hosoya M
Clin Nephrol; 2010 Jun; 73(6):482-6. PubMed ID: 20497762
[TBL] [Abstract][Full Text] [Related]
8. Posterior reversible encephalopathy syndrome after kidney transplantation in pediatric recipients: Two cases.
Giussani A; Ardissino G; Belingheri M; Dilena R; Raiteri M; Pasciucco A; Colico C; Beretta C
Pediatr Transplant; 2016 Feb; 20(1):68-71. PubMed ID: 26607205
[TBL] [Abstract][Full Text] [Related]
9. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation.
Hayes D; Adler B; Turner TL; Mansour HM
Pediatr Neurol; 2014 Mar; 50(3):272-5. PubMed ID: 24405697
[TBL] [Abstract][Full Text] [Related]
10. Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient.
Loar RW; Patterson MC; O'Leary PW; Driscoll DJ; Johnson JN
Pediatr Transplant; 2013 Mar; 17(2):E67-70. PubMed ID: 23331314
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors in heart transplantation.
Keogh A
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
[TBL] [Abstract][Full Text] [Related]
12. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
Fuchs U; Klein S; Zittermann A; Ensminger SM; Schulz U; Gummert JF
Ann Transplant; 2014 Jun; 19():300-4. PubMed ID: 24953848
[TBL] [Abstract][Full Text] [Related]
13. Overdose of Tacrolimus as the Trigger Causing Progression of Posterior Reversible Encephalopathy Syndrome and Subsequent Hepatic Infarction After Liver Transplant: A Case Report.
Tseng WC; Lai HC; Yeh CC; Fan HL; Wu ZF
Exp Clin Transplant; 2020 Feb; 18(1):128-132. PubMed ID: 30602365
[TBL] [Abstract][Full Text] [Related]
14. Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation.
Barbas AS; Rege AS; Castleberry AW; Gommer J; Ellis MJ; Brennan TV; Collins BH; Martin AE; Ravindra KV; Vikraman DS; Sudan DL
Am J Transplant; 2013 Mar; 13(3):808-10. PubMed ID: 23331705
[TBL] [Abstract][Full Text] [Related]
15. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
Burnett MM; Hess CP; Roberts JP; Bass NM; Douglas VC; Josephson SA
Clin Neurol Neurosurg; 2010 Dec; 112(10):886-91. PubMed ID: 20800343
[TBL] [Abstract][Full Text] [Related]
16. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
[TBL] [Abstract][Full Text] [Related]
17. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
19. [Reversible posterior leukoencephalopathy induced by tacrolimus in a renal transplant patient].
Izquierdo Pajuelo MJ; Jiménez Delgado JD; Rangel Mayoral JF; Liso Rubio FJ
Farm Hosp; 2009; 33(3):177-8. PubMed ID: 19712604
[No Abstract] [Full Text] [Related]
20. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
